Back to search

Netherlands· NL-a1a84503b9c9

Gaviscon 250 mg aardbei, kauwtabletten

A alginic acid product containing calciumcarbonaat (e 170) + natriumalginaat (e 401) + natriumwaterstofcarbonaat (e 500 (ii)), registered in Netherlands by Reckitt Benckiser Healthcare B.V.. The same ATC class is registered in 10 of our 19 countries.

ATC A02BX13

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedGaviscon 250 mg aardbei, kauwtablettenATCA02BX13REGISTER NO.NL-a1a84503b9c9PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Alginic acid is registered in 10 of 19 countries.

Countries holding a registration under ATC A02BX13 (alginic acid), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose

Alginic acid · ATC A02BX13

10 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CALCIUMCARBONAAT (E 170) + NATRIUMALGINAAT (E 401) + NATRIUMWATERSTOFCARBONAAT (E 500 (II))
Manufacturer
Reckitt Benckiser Healthcare B.V.
Country
Netherlands (NL)
ATC code
A02BX13
ATC class
Alginic acid
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    31439

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/79f5de04-1af0-4bb9-b3a5-9f71844e9630
GET /v1/drugs/79f5de04-1af0-4bb9-b3a5-9f71844e9630?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kauwtablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h31439_smpc.pdf",
  "strength": null,
  "atc_label": "Alginic Acid",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg31439",
  "excipients": [
    "AARDBEIENCRÈMESMAAKSTOF PHS-048481 Givaudan",
    "ASPARTAAM (E 951)",
    "CARMELLOSE NATRIUM (E 466)",
    "IJZEROXIDE ROOD  (E 172)",
    "MACROGOL 20000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MALTODEXTRINE",
    "MANNITOL (D-) (E 421)",
    "MAÏSZETMEEL, GEMODIFICEERD",
    "PLANTAARDIGE OLIE",
    "PROPYLEENGLYCOL (E 1520)",
    "XYLITOL (E 967)"
  ],
  "substances": [
    "CALCIUMCARBONAAT (E 170)",
    "NATRIUMALGINAAT (E 401)",
    "NATRIUMWATERSTOFCARBONAAT (E 500 (II))"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h31439.pdf",
  "authorised_at": "2005/03/08",
  "procedure_number": "IE/H/0740/001",
  "dispensing_status": "Algemene verkoop [conform voorwaarden CBG AV-lijst d.d. 6 september 2007]",
  "registration_number": "31439",
  "additional_monitoring": "N"
}

See everything about alginic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.